Found 861 clinical trials
Diabetic Kidney Disease
We are seeking adult participants with Type 2 Diabetic Kidney Disease for a clinical research study to evaluate the effectiveness of two study medications. This study is assessing whether the
- 0 views
- 26 Jan, 2023
- 1 location
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease
- 1 views
- 29 Jul, 2021
- 1 location
A Phase 2a, Double-blind, Randomized, Placebo-controlled, Proof of Concept Study of Vascular Endothelial Growth Factor (VEGF)-B Blockade with the Monoclonal Antibody CSL346 in Subjects with Diabetic Kidney Disease
This is a prospective, multicenter, randomized, double-blind, placebo-controlled, proof of concept study to investigate the efficacy, safety, tolerability, and pharmacokinetics (PK) of repeat doses of CSL346 in 100 subjects with DKD and albuminuria receiving standard of care treatment.
- 30 views
- 12 Oct, 2021
- 1 location
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Study To Evaluate The Safety And Efficacy Of Oral Difelikefalin In Advanced Chronic Kidney Disease Subjects With Moderate-To-Severe Pruritus And Not On Dialysis With An Up To 52-Week Long-Term Extension
Global: 400 male and female subjects (200 per treatment group) with advanced CKD who are not on dialysis will be enrolled in the study. The sample size may be increased to 550 subjects based on the results of a planned interim assessment conducted when approximately 50% of the planned 400 …
- 0 views
- 29 Sep, 2022
- 1 location
- 14 views
- 26 Jan, 2023
- 1 location
Kidney Disease in Type 2 Diabetics
Kidney Disease in Type 2 Diabetics
- 1362 views
- 25 Mar, 2021
- 1 location
RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
- 218 views
- 25 Mar, 2021
- 1 location
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven PhaseIII study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease insubjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
progression of kidney disease insubjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
- 177 views
- 23 Nov, 2020
- 1 location
BAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
- 1061 views
- 25 Mar, 2021
- 1 location
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
INDICATION: Treatment of hypertension in patients with uncontrolled hypertension and chronic kidney disease (CKD)
- 0 views
- 29 Sep, 2022
- 1 location